Price
No data yet.
Social Signal Score
Analyst Ratings
38 analystsRevenue
$25.62B+29.27%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Fernando Fernandez
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Employees
- 96,092
- Beta
- 0.42
- Country
- GB
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 3.03
Financials
Revenue
$25.62B+29.3%Net Income
$3.32B+39.8%EBITDA
$5.89B+95.2%Free Cash Flow
$1.76B-14.8%EPS (diluted)
$1.40+40.0%Shares Outstanding (diluted)
2.18B-26.8%Operating Expenses
$0.00Cash & Debt
$5.87BReturn of Capital
$3.61BDividend per Share
$0.52Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $50.50B | $9.47B | $4.33 |
| 2024 | $60.76B | $5.74B | $2.29 |
| 2023 | $59.60B | $6.49B | $2.56 |
| 2022 | $60.07B | $7.64B | $3.00 |
| 2021 | $52.44B | $6.05B | $2.33 |
| 2020 | $50.72B | $5.58B | $2.12 |
| 2019 | $51.98B | $5.63B | $2.14 |
| 2018 | $50.98B | $9.37B | $3.48 |
| 2017 | $53.72B | $6.02B | $2.14 |
| 2016 | $52.71B | $5.18B | $1.83 |
| 2015 | $53.27B | $4.91B | $1.73 |
| 2014 | $48.44B | $5.17B | $1.79 |
| 2013 | $49.80B | $4.84B | $1.71 |
| 2012 | $51.32B | $4.48B | $1.58 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from UL's reported EPS growth of 8.1% a year over 13 years.
- EPS in 5 years
- $6.40
- Implied price
- $83.20
- Return from $63.82
- 5.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $41.37 — -35.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| -1.9% | -11.1% | -7.5% | -4.3% | -1.5% | 1.0% |
| 3.1% | -6.6% | -2.7% | 0.6% | 3.5% | 6.1% |
| 8.1% | -2.0% | 2.0% | 5.4% | 8.5% | 11.3% |
| 13.1% | 2.5% | 6.7% | 10.3% | 13.5% | 16.4% |
| 18.1% | 7.0% | 11.4% | 15.2% | 18.5% | 21.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+0.00%Social Signal Score
Mentions (22)
- News247wallst.com·3d ago·Positive
Unilever and Diageo Took Different Paths in 2026. One Looks Better for Income Two British consumer giants, two very different years for shareholders. One slashed its payout while the other kept raising it, and the cheaper stock is not the safer bet.
View source ↗ - Newsseekingalpha.com·5d ago·Positive
Unilever: More Than Just A Defensive Dividend Stock I maintain a Buy rating on Unilever's volume-led growth, potential margin improvement, and reasonable valuation, which support the investment case. Q3 underlying sales grew 5.2%, including 2.9% volume growth; UL raised its full-year volume growth outlook to at least 3%. The planned Foods combination with McCormick should sharpen UL's growth profile, although regulatory delays, stranded costs, and restructuring costs remain risks.
View source ↗ - Newswsj.com·11d ago·Neutral
McCormick's $65 Billion Unilever Foods Merger Could Harm Competition, U.K. Regulator Warns The competition regulator gave the companies one week to address its concerns.
View source ↗ - Newsreuters.com·17d ago·Negative
Unilever to sell Myanmar joint venture stake, deal expected to close in 2027 Unilever to sell Myanmar joint venture stake, deal expected to close in 2027
View source ↗ - Newsmarketbeat.com·18d ago·Neutral
Unilever Targets 4%-6% Sales Growth and Higher Margins After Foods Separation Unilever NYSE: UL set out a plan to grow annual underlying sales by 4% to 6%, with at least 2% volume growth, as it prepares to focus on beauty, personal care and home care following the planned separation of its Foods business.
View source ↗ - Newswsj.com·19d ago·Neutral
Unilever Eyes $1.1 Billion in Savings as It Plans Leaner Future Away From Food The consumer-goods group will outline plans at an investor event Wednesday to save 1 billion euros by the end of 2029 by recuperating some costs and overhauling operations.
View source ↗ - Newsseekingalpha.com·25d ago·Positive
Unilever PLC (UL) Q3 2026 Sales/Trading Call Transcript Unilever PLC (UL) Q3 2026 Sales/Trading Call Transcript
View source ↗ - Newswsj.com·25d ago·Neutral
Unilever Brightens Volume Outlook After Sales Rise The maker of Dove soap booked turnover of $14.80 billion in the third quarter.
View source ↗ - Newsreuters.com·25d ago·Positive
Dove maker Unilever beats quarterly sales estimates on strong demand, pricing Consumer goods major Unilever reported third-quarter underlying sales growth of 5.
View source ↗ - Newsreuters.com·26d ago·Neutral
Dutch regulator blocks takeover of Unilever's Unox brand Dutch market regulator ACM on Tuesday said it would not allow the takeover of Unilever's Dutch soup and sausage brand Unox by Zwanenberg Food Group.
View source ↗ - Newsbusinesswire.com·31d ago·Neutral
Unilever Named #1 Core Non-Food Supplier Across All Channels in 2026 Advantage Awards HOBOKEN, N.J.--(BUSINESS WIRE)--Advantage Group International named Unilever the #1 Supplier in Core Non-Food, All Channels in the United States as part of the 2026 Advantage Awards.
View source ↗ - Newswsj.com·34d ago·Negative
Unilever Agrees to Sell Welly Bandage Business to Private-Equity Firm Forward Consumer Partners is acquiring the company known for its colorful bandages and bringing back its founder as an adviser.
View source ↗ - Newsproactiveinvestors.com·48d ago·Positive
Unilever on JP Morgan positive watch as Haleon faces caution Unilever PLC (LSE:ULVR) is on JP Morgan's 'positive watch', and Haleon PLC (LSE:HLN, NYSE:HLN) on 'negative watch', ahead of third-quarter reporting by European consumer staples companies. The note adds Givaudan to positive watch alongside Unilever, Heineken N.V.
View source ↗ - Newsmarketbeat.com·51d ago·Positive
McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside The main criticism has long been McCormick's persistently high valuation, typically at the high end of the consumer discretionary range, creating a hurdle for value-conscious investors—but that hurdle is not present this year. Trading at approximately 15x its current-year earnings forecast, the stock is as cheap as it's going to get, and a robust recovery could lie ahead.
View source ↗ - Newsreuters.com·67d ago·Neutral
Unilever won't discuss blanket two-year global worker guarantee in McCormick deal, IUF says Unilever "refuses to engage" with union body IUF over demands that a two-year employment guarantee agreed with European workers under its planned food business merger with McCormick be applied to all staff globally, the IUF said in a memo seen by Reuters.
View source ↗ - Newsreuters.com·67d ago·Negative
McCormick and Unilever food deal faces UK competition scrutiny Britain's competition regulator on Wednesday said it has launched an investigation into McCormick & Company's planned acquisition of the majority of Unilever's foods business to assess whether the deal could reduce competition in UK markets.
View source ↗ - Newsseekingalpha.com·73d ago·Neutral
Unilever: 15-Year-High Volume Growth Isn't Enough Unilever PLC remains a Hold, as its current valuation reflects a balanced risk-reward and leaves little margin of safety. UL delivered its strongest volume growth in over 15 years, with Q2 underlying sales up 5.8% and margin improvement, supported by emerging markets. Portfolio streamlining, including potential divestitures and the McCormick deal, positions UL for capital influx and future buybacks, but macro and private label risks persist.
View source ↗ - Newsbusinesswire.com·79d ago·Neutral
CauzzyAI and Unilever Prestige Partner to Accelerate AI Innovation Across Prestige Beauty LOS ANGELES--(BUSINESS WIRE)-- #ai--CauzzyAI (cauzzy.ai) today announced a strategic partnership with Unilever Prestige, bringing its Enterprise AI platform within the Unilever Prestige portfolio. The collaboration marks a significant milestone in Unilever Prestige's vision to become an AI-native enterprise, embedding intelligent AI into everyday business operations to accelerate innovation, simplify comple
View source ↗ - Newsreuters.com·89d ago·Positive
Death of the consumer conglomerate? Unilever bets less is more Unilever is betting that shedding food assets and focusing on beauty, personal care and home products will close a valuation gap with more focused rivals. The challenge is convincing investors that a simpler company can deliver higher returns.
View source ↗ - Newsseekingalpha.com·90d ago·Positive
… To Emerging Market Growth Unilever offers unique exposure to emerging market growth, with 60% of revenue sourced from developing economies—double that of key peers. UL combines high emerging market growth (Q2 2026: 8.9% in Latin America, 10% in India) with developed-market defensiveness (24-month Beta of 0.16). The company's local production, established brand loyalty, and rural micro-distribution network are difficult to replicate, providing a deep competitive moat in emerging markets.
View source ↗ - Newsnypost.com·91d ago·Negative
Judge dismisses major parts of Ben & Jerry's lawsuit accusing Unilever of silencing social activism The dismissed claims relate primarily to how Ben and Jerry's operates, while the two claims that survived in full relate to missed payments by Unilever.
View source ↗ - Newsreuters.com·93d ago·Negative
Judge narrows Ben & Jerry's lawsuit accusing Unilever of silencing social activism A federal judge on Friday dismissed major portions of a Ben & Jerry's lawsuit accusing its former parent Unilever of trying to silence the ice cream maker's social activism, dismantle its board and stop funding its namesake foundation.
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $1.84 per share
Typical surprise -8.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$1.83 vs $1.84miss
- Thu, Feb 12$1.37 vs $1.75miss
- Thu, Jul 31$1.67 vs $1.83miss
- Thu, Feb 13$0.84 vs $1.53miss
- Thu, Jul 25$1.58 vs $1.67miss
- Thu, Feb 8$1.28 vs $1.41miss
Estimates and results for UL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (41d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Sell$1,001 - $15,000
- Sheri Biggshouse · SC03 · disclosed Oct 6, 2025 (202d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (65d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Sell$1,001 - $15,000
- Bruce Westermanhouse · AR04 · disclosed May 13, 2025 (22d later)Sell$1,001 - $15,000
- Bruce Westermanhouse · AR04 · disclosed Apr 17, 2025 (45d later)Buy$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (119d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (297d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2024 (24d later)Buy$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed May 20, 2024 (41d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Apr 24, 2024 (33d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (26d later)Sell$1,001 - $15,000
- Earl Blumenauerhouse · OR03 · disclosed Mar 2, 2024 (19d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (26d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 6, 2023 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (26d later)Buy$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$100,001 - $250,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
